Product Information

IMVEXXY 4 MCG STARTER PACK is a brand product labeled by Mayne Pharma, priced at $26.9671 per EA under NDC 68308074718. Its NADAC has been published 105 times since Nov 13, 2024.

FDA first approved this application on May 29, 2018. Its Orange Book therapeutic-equivalence code is AB — FDA rates it therapeutically equivalent to (substitutable for) its reference product.

The High Outlier badge above means this manufacturer's average price in the estradiol market falls above Q3 + 1.5·IQR across all competing manufacturers. We only apply this flag in markets with four or more competitors. Full definition: glossary → outlier.

IMVEXXY 4 MCG STARTER PACK

estradiol
$26.9671per EA
High Outlier

Strength

4 ug/1

Manufacturer

Mayne Pharma

NDC

68308074718

Classification

Brand

Dosage Form

INSERT

Route

VAGINAL

Effective Date

10/21/2026

Active Ingredients

ESTRADIOL

Approval Type

New Drug (NDA)

FDA Application

NDA208564

FDA Approved

5/29/2018

TE Code

AB

On Market Since

5/3/2024

Pharmacological Classes

Estradiol Congeners
Estrogen Receptor Agonists
Estrogen

Price Statistics

The NADAC for IMVEXXY 4 MCG STARTER PACK has been published 105 times since Nov 13, 2024, and over the history we have for it it has risen 4.1%. The table below summarizes its recorded NADAC range and movement.

Current price$26.9671 per EA
All-time high$27.1090 (Oct 14, 2026)
All-time low$25.8181 (May 20, 2026)
52-week high$27.1090
52-week low$25.8181
Median price$25.8732
Average price$26.1404
Largest weekly change+5.0% (Jun 3, 2026)
Weeks tracked105
Tracking sinceNov 13, 2024

Price History

1W

0.0%

1M

-0.5%

3M

-0.5%

6M

+4.4%

1Y

+4.4%

3Y

N/A

5Y

N/A

All

+4.1%

Generic Alternatives

The matcher finds 1 manufacturer offering a NADAC-published product with this drug's active ingredient and strength in a comparable dosage form (cheapest from each manufacturer, up to 10 shown below). None of the shown alternatives sit below the current price. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.

Lowest-Cost Alternatives

1 alternative • Same active ingredient

Continue researching this drug

Use these direct paths to move from a single NDC into the surrounding market, manufacturer, class, and trend context.

Frequently asked questions

What is the NADAC price of IMVEXXY 4 MCG STARTER PACK?

The current National Average Drug Acquisition Cost (NADAC) for IMVEXXY 4 MCG STARTER PACK, manufactured by Mayne Pharma, is $26.9671 per EA (NDC 68308074718), effective Nov 11, 2026.

How has the price of IMVEXXY 4 MCG STARTER PACK changed over time?

Over the history we have for it, the NADAC for IMVEXXY 4 MCG STARTER PACK has risen 4.1%. It has been tracked across 105 weekly CMS publications since Nov 13, 2024.

What are the highest and lowest recorded NADAC prices for IMVEXXY 4 MCG STARTER PACK?

Since Nov 13, 2024, the NADAC for IMVEXXY 4 MCG STARTER PACK has ranged from a low of $25.8181 (May 20, 2026) to a high of $27.1090 (Oct 14, 2026), with a median of $25.8732 per EA.

Are there cheaper alternatives to IMVEXXY 4 MCG STARTER PACK?

1 manufacturer publishes a NADAC-priced product with the same active ingredient and strength as IMVEXXY 4 MCG STARTER PACK in a comparable dosage form, but none are currently priced below it.

Who manufactures IMVEXXY 4 MCG STARTER PACK?

IMVEXXY 4 MCG STARTER PACK (NDC 68308074718) is labeled by Mayne Pharma, and CMS classifies it as a brand product.